|
Items
|
Pyrroloquinoline quinone disodium levels,%
|
SEM
|
P-value
|
|---|
|
0
|
0.15
|
0.30
|
0.45
|
ANOVA
|
Linear
|
Quadratic
|
|---|
|
Serum
|
|
SOD, U/mg
|
46.42b
|
47.04b
|
52.95a
|
50.24ab
|
1.37
|
0.01
|
0.09
|
0.23
|
|
GSH-Px, U/mg
|
727.62b
|
688.16b
|
812.73a
|
908.16a
|
35.90
|
0.02
|
0.06
|
0.19
|
|
MDA, nmol/mg
|
3.09a
|
2.52ab
|
2.30b
|
2.25b
|
0.20
|
< 0.01
|
< 0.01
|
0.07
|
|
CAT, IU/mg
|
3.14
|
4.00
|
4.57
|
3.62
|
0.48
|
0.21
|
0.36
|
0.07
|
|
Liver
|
|
SOD, U/mg
|
156.16b
|
161.53b
|
183.95ab
|
222.86a
|
11.10
|
< 0.01
|
< 0.01
|
0.15
|
|
GSH-Px, U/mg
|
968.42b
|
974.70b
|
1041.32a
|
1029.44ab
|
17.14
|
< 0.01
|
0.12
|
0.49
|
|
MDA, nmol/mg
|
3.38a
|
3.12a
|
1.45b
|
1.64b
|
0.32
|
0.01
|
0.05
|
0.60
|
|
CAT, U/mg
|
38.12
|
39.88
|
40.71
|
45.39
|
4.71
|
0.73
|
0.30
|
0.76
|
|
Heart
|
|
SOD, U/mg
|
163.34
|
171.12
|
184.78
|
193.39
|
8.40
|
0.09
|
0.01
|
0.96
|
|
GSH-Px, U/mg
|
500.78b
|
548.85a
|
544.61a
|
537.97a
|
19.24
|
< 0.01
|
0.09
|
0.06
|
|
MDA, nmol/mg
|
3.53
|
4.41
|
2.82
|
1.66
|
0.35
|
0.31
|
0.23
|
0.17
|
|
CAT, U/mg
|
4.16
|
3.92
|
4.35
|
4.31
|
1.04
|
0.99
|
0.85
|
0.92
|
- 1 SEM standard error of the mean; the values are means ± SEM; 6 replicates. The linear and quadratic differences are with respect to pyrroloquinoline quinone disodium levels. Means within a row lacking a common letter are significantly different (P < 0.05). Antioxidant activities are expressed per mg of protein